Form D · Pharmaceuticals
Petros Pharmaceuticals, Inc.
New York, NY · CIK 0001815903
Offering snapshot reported Jul 21, 2023 · SEC filing
- Reported sold
- $30M Offering amount: $30M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 13, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 21, 2023 | Initial | $30,000,006 | No comparison | 15 | SEC filing |
| Jan 3, 2022 | Initial | $2,200,023 | No comparison | 12 | SEC filing |
| Dec 3, 2021 | Initial | $3,540,000 | No comparison | 12 | SEC filing |
| Oct 26, 2021 | Initial | $0 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.2M
- Finders' fees
- $0
- Form D file number
- 021-487617
Includes aggregate exercise price of warrants of $2.25 (subject to price-based adjustment), that may be received upon exercise of the warrants
Issuer issued to placement agent (and its designees) warrants to purchase up to 533,334 shares at an exercise price of $2.25 (subject to price-based adjustment) under Section 4(a)(2)
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Katalyst Securities LLC | 112494 |
Source: Form D, filed Jul 21, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mitchell Arnold | Executive |
| Bruce T. Bernstein | Director |
| Fady Boctor | Executive |
| Gregory Bradley | Director |
| Andrew Gesek | Executive |
| John D. Shulman | Director |
| Joshua N. Silverman | Director |
| Wayne R. Walker | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1185 Avenue Of The Americas 3 Rd Floor
New York, NY, 10036
New York, NY, 10036